Amanda Bynes' Insensitive Cancer Tweet Enrages Followers

Actress Amanda Bynes has been acting very odd lately, but last night, many believe she crossed the line,

If you're not into Twitter, or if you're not among those watching actress Amanda Bynes publicly collapse under the weight of what appears to be some collection of mental disorders, you likely did not see Bynes' tweet after apparently shaving her head.

In a moment of astonishing insensitivity, she tweeted,
"Not having hair makes me feel like a cancer patient."

The backlash was as swift as it was predictable, with many thousands of her 2 million followers reacting angrily to the comment.

None of the reactions got as much attention as that of leukemia patient Erin Tarantino (in remission), who fired back at Bynes with a tweet and a picture that said what a lot of people were thinking – that this time, Bynes had gone too far.

Here's the original set of tweets:

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap